Semin Neurol 2004; 24(3): 249-259
DOI: 10.1055/s-2004-835066
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

The Restless Legs Syndrome and Periodic Limb Movement Disorder: A Review of Management

Suzanne Lesage1 , Wayne A. Hening2
  • 1RLS Center, Department of Neurology, Johns Hopkins Medical School, Baltimore, Maryland
  • 2Department of Neurology, UMDNJ-RW Johnson Medical School, New Brunswick, New Jersey
Further Information

Publication History

Publication Date:
27 September 2004 (online)

The restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are distinguishable but overlapping disorders. Both feature nocturnal involuntary limb movements (periodic limb movements) that can cause sleep disruption, but each has distinct clinical features that are relevant to the diagnosis and management of the patient. The diagnosis of RLS is made by meeting established clinical criteria, not from discovery of periodic limb movements of sleep (PLMS) on a sleep study. PLMD, however, does require the presence of PLMS on polysomnography as well as an associated sleep complaint. Moreover, PLMS are themselves nonspecific, occurring both with RLS and with other sleep disorders as well as in normal individuals. The diagnosis of PLMD, then, requires not merely finding a significant number of PLMS but also excluding other potential causes for the associated sleep complaint. Treatment of RLS is based on consideration of the pattern and severity of the disorder, with dopaminergic drugs generally favored for initial treatment. Anticonvulsants, opioids, and sedative/hypnotics also have a role. A treatment algorithm is provided to assist with the management of RLS. Treatment of PLMD relies on many of the same medications, but is generally more straightforward and places a greater reliance on levodopa compounds and sedative-hypnotics.

REFERENCES

  • 1 Willis T. Two Discourses Concerning the Soul of Brutes. London; Dring, Harper, and Leigh 1683
  • 2 Ekbom K A. Restless legs: a clinical study.  Acta Med Scand Suppl. 1945;  158 1-122
  • 3 Ekbom K A. Restless legs syndrome.  Neurology. 1960;  10 868-873
  • 4 Allen R P, Picchietti D, Hening W A, Trenkwalder C, Walters A S, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.  Sleep Med. 2003;  4 101-119
  • 5 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.  Mov Disord. 1997;  12 61-65
  • 6 Trenkwalder C, Hening W A, Walters A S, Campbell S S, Rahman K, Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome.  Mov Disord. 1999;  14 102-110
  • 7 Allen R P, Earley C J. Restless legs syndrome: a review of clinical and pathophysiologic features.  J Clin Neurophysiol. 2001;  18 128-147
  • 8 Saletu M, Anderer P, Saletu B, Lindeck-Pozza L, Hauer C, Saletu-Zyhlarz G. EEG mapping in patients with restless legs syndrome as compared with normal controls.  Psychiatry Res. 2002;  115 49-61
  • 9 Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population.  Arch Intern Med. 2004;  164 196-202
  • 10 Rothdach A J, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.  Neurology. 2000;  54 1064-1068
  • 11 Tan E K, Seah A, See S J, Lim E, Wong M C, Koh K K. Restless legs syndrome in an Asian population: a study in Singapore.  Mov Disord. 2001;  16 577-579
  • 12 Sevim S, Dogu O, Camdeviren H et al.. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.  Neurology. 2003;  61 1562-1569
  • 13 Krishnan P R, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study.  Mov Disord. 2003;  18 181-185
  • 14 Hening W A, Walters A S, Allen R P, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms and Treatment) Primary Care study.  Sleep Med. 2004;  5 237-246
  • 15 Hui D S, Wong T Y, Ko F W et al.. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis.  Am J Kidney Dis. 2000;  36 783-788
  • 16 Hui D, Wong T, Li T et al.. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis.  Med Sci Monit. 2002;  8 CR331-CR336
  • 17 Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand G F, Oertel W H, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome.  Am J Kidney Dis. 1998;  31 324-328
  • 18 Lee K A, Zaffke M E, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.  J Womens Health Gend Based Med. 2001;  10 335-341
  • 19 Suzuki K, Ohida T, Sone T et al.. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems.  Sleep. 2003;  26 673-677
  • 20 Winkelman J W, Chertow G M, Lazarus J M. Restless legs syndrome in end-stage renal disease.  Am J Kidney Dis. 1996;  28 372-378
  • 21 Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.  Mov Disord. 2002;  17 1072-1076
  • 22 Benz R L, Pressman M R, Hovick E T, Peterson D D. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).  Am J Kidney Dis. 1999;  34 1089-1095
  • 23 Silber M H, Richardson J W. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome.  Mayo Clin Proc. 2003;  78 52-54
  • 24 Polydefkis M, Allen R P, Hauer P, Earley C J, Griffin J W, McArthur J C. Subclinical sensory neuropathy in late-onset restless legs syndrome.  Neurology. 2000;  55 1115-1121
  • 25 Gemignani F, Marbini A, Di Giovanni G et al.. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome.  J Neurol Sci. 1997;  152 218-223
  • 26 Gemignani F, Marbini A, Di Giovanni G, Salih S, Terzano M G. Charcot-Marie-Tooth disease type 2 with restless legs syndrome.  Neurology. 1999;  52 1064-1066
  • 27 Abele M, Burk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3.  J Neurol. 2001;  248 311-314
  • 28 Schols L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?.  Neurology. 1998;  51 1603-1607
  • 29 Banno K, Delaive K, Walld R, Kryger M H. Restless legs syndrome in 218 patients: associated disorders.  Sleep Med. 2000;  1 221-229
  • 30 Salih A M, Gray R E, Mills K R, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis.  Br J Rheumatol. 1994;  33 60-63
  • 31 Ondo W, Tan E K, Mansoor J. Rheumatologic serologies in secondary restless legs syndrome.  Mov Disord. 2000;  15 321-323
  • 32 Ondo W G, Vuong K D, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome.  Arch Neurol. 2002;  59 421-424
  • 33 Allen R P, Earley C J. Augmentation of the restless legs syndrome with carbidopa/levodopa.  Sleep. 1996;  19 205-213
  • 34 Walters A S, LeBrocq C, Passi V et al.. A preliminary look at the percentage of patients with restless legs syndrome who also have Parkinson disease, essential tremor or tourette syndrome in a single practice.  J Sleep Res. 2003;  12 343-345
  • 35 Agargun M Y, Kara H, Ozbek H, Tombul T, Ozer O A. Restless legs syndrome induced by mirtazapine.  J Clin Psychiatry. 2002;  63 1179
  • 36 Bakshi R. Fluoxetine and restless legs syndrome.  J Neurol Sci. 1996;  142 151-152
  • 37 Hargrave R, Beckley D J. Restless leg syndrome exacerbated by sertraline.  Psychosomatics. 1998;  39 177-178
  • 38 Sanz-Fuentenebro F J, Huidobro A, Tejadas-Rivas A. Restless legs syndrome and paroxetine.  Acta Psychiatr Scand. 1996;  94 482-484
  • 39 Walters A S, Hening W, Rubinstein M, Chokroverty S. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.  Sleep. 1991;  14 339-345
  • 40 Chesson Jr A L, Ferber R A, Fry J M et al.. The indications for polysomnography and related procedures.  Sleep. 1997;  20 423-487
  • 41 Littner M, Hirshkowitz M, Kramer M et al.. Practice parameters for using polysomnography to evaluate insomnia: an update.  Sleep. 2003;  26 754-760
  • 42 Gorny S, Allen R, Krausman D, Earley C. Evaluation of the PAM-RL system for the detection of periodic leg movements during sleep in the lab and home environments.  Sleep. 1998;  21 183 , Abstract
  • 43 Allen R P. Ambulatory activity monitoring. In: Chokroverty S, Hening WA, Walters AS Sleep and Movement Disorders Philadelphia; Butterworth-Heinemann 2003: 144-152
  • 44 O'Keeffe S T, Gavin K, Lavan J N. Iron status and restless legs syndrome in the elderly.  Age Ageing. 1994;  23 200-203
  • 45 Sun E R, Chen C A, Ho G, Earley C J, Allen R P. Iron and the restless legs syndrome.  Sleep. 1998;  21 371-377
  • 46 Barton J C, Wooten V D, Acton R T. Hemochromatosis and iron therapy of restless legs syndrome.  Sleep Med. 2001;  2 249-251
  • 47 Earley C J. Hemochromatosis and iron therapy of restless legs syndrome.  Sleep Med. 2001;  2 181-183
  • 48 Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study.  Sleep. 1998;  21 501-505
  • 49 Staedt J, Stoppe G, Kogler A et al.. Nightly myoclonus syndrome (NMS) and restless legs syndrome (RLS): review and case report [in German].  Fortschr Neurol Psychiatr. 1994;  62 88-93
  • 50 Eisensehr I, Wetter T C, Linke R et al.. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.  Neurology. 2001;  57 1307-1309
  • 51 Michaud M, Soucy J P, Chabli A, Lavigne G, Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep.  J Neurol. 2002;  249 164-170
  • 52 Ruottinen H M, Partinen M, Hublin C et al.. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.  Neurology. 2000;  54 502-504
  • 53 Trenkwalder C, Walters A S, Hening W A et al.. Positron emission tomographic studies in restless legs syndrome.  Mov Disord. 1999;  14 141-145
  • 54 Turjanski N, Lees A J, Brooks D J. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.  Neurology. 1999;  52 932-937
  • 55 Connor J R, Boyer P J, Menzies S L, Dellinger B, Allen R P, Earley C J. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.  Neurology. 2003;  61 304-309
  • 56 Tergau F, Wischer S, Paulus W. Motor system excitability in patients with restless legs syndrome.  Neurology. 1999;  52 1060-1063
  • 57 Quatrale R, Manconi M, Gastaldo E et al.. Neurophysiological study of corticomotor pathways in restless legs syndrome.  Clin Neurophysiol. 2003;  114 1638-1645
  • 58 Earley C J, Allen R P, Beard J L, Connor J R. Insight into the pathophysiology of restless legs syndrome.  J Neurosci Res. 2000;  62 623-628
  • 59 Allen R P, Barker P B, Wehrl F, Song H K, Earley C J. MRI measurement of brain iron in patients with restless legs syndrome.  Neurology. 2001;  56 263-265
  • 60 Earley C J, Connors J R, Allen R P. RLS patients have abnormally reduced CSF ferritin compared to normal controls.  Neurology. 1999;  52(suppl 2) A111-A112
  • 61 Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide.  Arch Neurol. 1982;  39 739
  • 62 Montplaisir J, Godbout R, Poirier G, Bédard M A. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa.  Clin Neuropharmacol. 1986;  9 456-463
  • 63 Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review.  Sleep. 1999;  22 970-999
  • 64 Hening W A, Allen R P, Earley C J, Picchietti D L, Silber M. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine interim review.  Sleep. 2004;  27 560-583
  • 65 Silber M H, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study.  Sleep. 2003;  26 819-821
  • 66 Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.  Neurology. 2002;  59 1573-1579
  • 67 Walters A S, Wagner M L, Hening W A et al.. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.  Sleep. 1993;  16 327-332
  • 68 The Atlas Task Force . Recording and scoring leg movements.  Sleep. 1993;  16 748-759
  • 69 Michaud M, Poirier G, Lavigne G, Montplaisir J. Restless legs syndrome: scoring criteria for leg movements recorded during the suggested immobilization test.  Sleep Med. 2001;  2 317-321
  • 70 Diagnostic Classification Steering Committee of the American Sleep Disorders Association (M. J. Thorpy-Chairperson) .The International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN; American Sleep Disorders Association 1997
  • 71 Wetter T C, Pollmacher T. Restless legs and periodic leg movements in sleep syndromes.  J Neurol. 1997;  244 S37-S45
  • 72 Fantini M L, Michaud M, Gosselin N, Lavigne G, Montplaisir J. Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation.  Neurology. 2002;  59 1889-1894
  • 73 Smith R C. Relationship of periodic movements in sleep (nocturnal myoclonus) and the Babinski sign.  Sleep. 1985;  8 239-243
  • 74 Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex.  Neurology. 2000;  54 1609-1616
  • 75 Trenkwalder C, Bucher S F, Oertel W H. Electrophysiological pattern of involuntary limb movements in the restless legs syndrome.  Muscle Nerve. 1996;  19 155-162
  • 76 Provini F, Vetrugno R, Meletti S et al.. Motor pattern of periodic limb movements during sleep.  Neurology. 2001;  57 300-304
  • 77 de Weerd A W, Rijsman R M, Brinkley A. Activity patterns of leg muscles in periodic limb movement disorder.  J Neurol Neurosurg Psychiatry. 2004;  75 317-319
  • 78 Simakajornboon N, Gozal D, Vlasic V, Mack C, Sharon D, McGinley B M. Periodic limb movements in sleep and iron status in children.  Sleep. 2003;  26 735-738
  • 79 Ancoli-Israel S, Kripke D F, Mason W, Kaplan O J. Sleep apnea and periodic movements in an aging sample.  J Gerontol. 1985;  40 419-425
  • 80 Nicolas A, Lespérance P, Montplaisir J. Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category?.  Eur Neurol. 1998;  40 22-26
  • 81 Eisensehr I, Ehrenberg B L, Noachtar S. Different sleep characteristics in restless legs syndrome and periodic limb movement disorder.  Sleep Med. 2003;  4 147-152

Suzanne LesageM.D. 

RLS Center, Asthma and Allergy, 1B76, Johns Hopkins Bayview Medical Center

5501 Hopkins Bayview Circle, Baltimore, MD 21224

    >